These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 25845297)

  • 1. Management of diabetic nephropathy: Recent progress and future perspective.
    Ahmad J
    Diabetes Metab Syndr; 2015; 9(4):343-58. PubMed ID: 25845297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current update in the management of diabetic nephropathy.
    Van Buren PN; Toto R
    Curr Diabetes Rev; 2013 Jan; 9(1):62-77. PubMed ID: 23167665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in the management of diabetic nephropathy.
    Waanders F; Visser FW; Gans RO
    Neth J Med; 2013 Nov; 71(9):448-58. PubMed ID: 24218418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective.
    Xue R; Gui D; Zheng L; Zhai R; Wang F; Wang N
    J Diabetes Res; 2017; 2017():1839809. PubMed ID: 28386567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing the development and progression of diabetic kidney disease: Where do we stand?
    Zagkotsis G; Markou M; Paschou E; Papanikolaou P; Sabanis N
    Diabetes Metab Syndr; 2018 Jul; 12(4):585-590. PubMed ID: 29602760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update of pathophysiology and management of diabetic kidney disease.
    Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
    J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy.
    Ilyas Z; Chaiban JT; Krikorian A
    Rev Endocr Metab Disord; 2017 Mar; 18(1):21-28. PubMed ID: 28289965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DIABETIC NEPHROPATHY AS A CAUSE OF CHRONIC KIDNEY DISEASE].
    Kos I; Prkačin I
    Acta Med Croatica; 2014 Dec; 68(4-5):375-81. PubMed ID: 26285470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic nephropathy -- a multifaceted target of new therapies.
    Choudhury D; Tuncel M; Levi M
    Discov Med; 2010 Nov; 10(54):406-15. PubMed ID: 21122472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in diabetic nephropathy.
    Marshall SM
    Postgrad Med J; 2004 Nov; 80(949):624-33. PubMed ID: 15537844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.
    Navarro-González JF; Muros M; Mora-Fernández C; Herrera H; Meneses B; García J
    J Diabetes Complications; 2011; 25(5):314-9. PubMed ID: 21144773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Type 2 diabetic nephropathy: clinical course and prevention proposals 2004].
    Tarchini R; Bottini E; Botti P; Marseglia CD; Talassi E; Baraldi O; Lambertini D; Gaetti L; Bellomi A
    G Ital Nefrol; 2005; 22 Suppl 31():S15-9. PubMed ID: 15786392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives.
    Lv M; Chen Z; Hu G; Li Q
    Drug Discov Today; 2015 Mar; 20(3):332-46. PubMed ID: 25448752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy: What does the future hold?
    Montero RM; Covic A; Gnudi L; Goldsmith D
    Int Urol Nephrol; 2016 Jan; 48(1):99-113. PubMed ID: 26438328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis, prevention, and treatment of diabetic nephropathy.
    Cooper ME
    Lancet; 1998 Jul; 352(9123):213-9. PubMed ID: 9683226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.